Inicio > BIGG > Resultado de la búsqueda

    Resultados: 2

    The advisory committee on immunization practices’ interim recommendation for use of Pfizer-Biontech Covid-19 vaccine in children aged 5–11 years: United States, november 2021

    Woodworth, Kate R; Moulia, Danielle; Collins, Jennifer P; Hadler, Stephen C; Jones, Jefferson M; Reddy, Sujan C; Chamberland, Mary; Campos-Outcalt, Doug; Morgan, Rebecca L; Brooks, Oliver; Talbot, H. Keipp; Lee, Grace M; Bell, Beth P; Daley, Matthew F; Mbaeyi, Sarah; Dooling, Kathleen; Oliver, Sara E.
    MMWR recomm. rep; 70 (45), 2022
    The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle–formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. On August 23, 2021, the Food and Drug Administration (FDA) approved a Biologics License Applicati...
    Vacuna BNT162/inmunología, Vacuna BNT162/uso terapéutico, Programas de Inmunización/normas, COVID-19/prevención & control
    Texto completo

    Interim recommendations of the advisory committee on immunization practices for use of Moderna and Pfizer-Biontech Covid-19 vaccines in children aged 6 months–5 years: United States, june 2022

    Fleming-Dutra, Katherine E; Wallace, Megan; Moulia, Danielle L; Twentyman, Evelyn; Roper, Lauren E; Hall, Elisha; Link-Gelles, Ruth; Godfrey, Monica; Woodworth, Kate R; Anderson, Tara C; Rubis, Amy B; Shanley, Edwin; Jones, Jefferson M; Morgan, Rebecca L; Brooks, H. Oliver; Talbot, Keipp; Lee, Grace M; Bell, Beth P; Meyer, Sarah; Daley, Matthew; Oliver, Sara E.
    MMWR recomm. rep; 71 (26), 2022
    On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months–5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 weeks apart, and BNT162b2 (Pfizer-BioNTech) COVID-19 va...
    Vacuna nCoV-2019 mRNA-1273/efectos adversos, Vacuna nCoV-2019 mRNA-1273/administración & dosificación, Vacuna BNT162/efectos adversos, Vacuna BNT162/administración & dosificación, Programas de Inmunización/normas, COVID-19/prevención & control
    Texto completo